Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hani Essa

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Cardiac Failure Review|April 11, 2022
The Impact of Frailty and Comorbidities on Heart Failure OutcomesThomas Salmon, Hani Essa, Behnam Tajik, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|June 22, 2026
Impact of new-onset atrial fibrillation on 12-month outcomes and mortality after esophagectomyHani Essa, Ashwin Balu, Brian Johnston, et al.
Neurogastroenterology and Motility|November 13, 2020
Hydrogen and methane breath test results are negatively associated with IBS and may reflect transit time in post-surgical patientsHani Essa, Shaheen Hamdy, Darren Green, et al.
BMJ Open|January 4, 2026
Intelligent monitoring to predict atrial fibrillation (NOTE-AF): clinical study 1 for the 'Health virtual twins for the personalised management of stroke related to atrial fibrillation (TARGET)' project - a protocol for a prospective cohort analysisHani Essa, Brian Johnston, Gregory Y H Lip, et al.
Clinical Therapeutics|August 30, 2023
Metformin and SGLT2i as First-line Combination Therapy in Type 2 Diabetes: A Real-world Study With a Focus on EthnicityMatthew Anson, Sizheng Steven Zhao, Hani Essa, et al.
ERJ Open Research|December 24, 2025
New-onset atrial fibrillation in patients with acute hypercapnic respiratory failure requiring noninvasive ventilationHani Essa, Ashwin Balu, Yusra Amanullah, et al.
Clinical Therapeutics|August 17, 2024
Aspirin and Ticagrelor Versus Aspirin and Clopidogrel or Prasugrel and the Effect on Staphylococcal-associated Infections: A Real-world StudyHani Essa, Wern Yew Ding, Faraz Rana, et al.
Current Vascular Pharmacology|March 15, 2023
"Renalism" with Renin Angiotensin Aldosterone System Inhibitor Use in Patients Enrolled in Trials for Heart Failure with Reduced Ejection Fraction and Advanced Chronic Kidney Disease: A Systematic ReviewHussein Al Sudani, Samir Shah, Kevin Bryan Lo, et al.
Diabetes, Obesity & Metabolism|June 29, 2023
All-cause mortality and cardiovascular outcomes with sodium-glucose Co-transporter 2 inhibitors, glucagon-like peptide-1 receptor agonists and with combination therapy in people with type 2 diabetesDavid R Riley, Hani Essa, Philip Austin, et al.
British Dental Journal|October 21, 2025
Increased cardiovascular risk in people with type 2 diabetes and periodontitis: an analysis from a global real-world federated databaseHani Essa, Ingeborg Welters, Iram Yasin, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Cardiac Failure Review|April 11, 2022
The Impact of Frailty and Comorbidities on Heart Failure OutcomesThomas Salmon, Hani Essa, Behnam Tajik, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|June 22, 2026
Impact of new-onset atrial fibrillation on 12-month outcomes and mortality after esophagectomyHani Essa, Ashwin Balu, Brian Johnston, et al.
Neurogastroenterology and Motility|November 13, 2020
Hydrogen and methane breath test results are negatively associated with IBS and may reflect transit time in post-surgical patientsHani Essa, Shaheen Hamdy, Darren Green, et al.
BMJ Open|January 4, 2026
Intelligent monitoring to predict atrial fibrillation (NOTE-AF): clinical study 1 for the 'Health virtual twins for the personalised management of stroke related to atrial fibrillation (TARGET)' project - a protocol for a prospective cohort analysisHani Essa, Brian Johnston, Gregory Y H Lip, et al.
Clinical Therapeutics|August 30, 2023
Metformin and SGLT2i as First-line Combination Therapy in Type 2 Diabetes: A Real-world Study With a Focus on EthnicityMatthew Anson, Sizheng Steven Zhao, Hani Essa, et al.
ERJ Open Research|December 24, 2025
New-onset atrial fibrillation in patients with acute hypercapnic respiratory failure requiring noninvasive ventilationHani Essa, Ashwin Balu, Yusra Amanullah, et al.
Clinical Therapeutics|August 17, 2024
Aspirin and Ticagrelor Versus Aspirin and Clopidogrel or Prasugrel and the Effect on Staphylococcal-associated Infections: A Real-world StudyHani Essa, Wern Yew Ding, Faraz Rana, et al.
Current Vascular Pharmacology|March 15, 2023
"Renalism" with Renin Angiotensin Aldosterone System Inhibitor Use in Patients Enrolled in Trials for Heart Failure with Reduced Ejection Fraction and Advanced Chronic Kidney Disease: A Systematic ReviewHussein Al Sudani, Samir Shah, Kevin Bryan Lo, et al.
Diabetes, Obesity & Metabolism|June 29, 2023
All-cause mortality and cardiovascular outcomes with sodium-glucose Co-transporter 2 inhibitors, glucagon-like peptide-1 receptor agonists and with combination therapy in people with type 2 diabetesDavid R Riley, Hani Essa, Philip Austin, et al.
British Dental Journal|October 21, 2025
Increased cardiovascular risk in people with type 2 diabetes and periodontitis: an analysis from a global real-world federated databaseHani Essa, Ingeborg Welters, Iram Yasin, et al.
Pageof 3